hPG80 (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.1073476
Abstract: Background Currently, the long-term prognosis and survival rate of patients with high-grade glial tumors remains poor and there are no biomarkers. hPG80 (circulating progastrin) secreted into the blood by tumor cells has been widely studied… read more here.
Keywords: high grade; glial tumors; grade glial; blood ... See more keywords